Skip to content

VOC-based Detection of Lung Cancer in Blood Samples using the PES-Sensor System

VOC-based Detection of Lung Cancer in Blood Samples using the PES-Sensor System - VOC-PES

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039827
Enrollment
30
Registered
2026-04-15
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Retrospective analysis of blood samples from patients with lung cancer using the detection of volatile organic compounds. The aim of the study is to demonstrate a statistically significant di

Sponsors

PES Technologies Limited
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of lung cancer Diagnosis of COPD

Exclusion criteria

Exclusion criteria: No Consent

Design outcomes

Primary

MeasureTime frame
The primary objective of the study is to demonstrate a statistically significant difference in sensor signatures between lung cancer samples and healthy control samples. The project is intended solely to provide initial scientific findings and proof of concept.

Secondary

MeasureTime frame
The secondary objectives are to evaluate diagnostic performance (AUROC, sensitivity/specificity) and feasibility (error rates, throughput).

Countries

Germany

Contacts

Public ContactMarc Schneider

Thoraxklinik-Heidelberg

marc.schneider@med.uni-heidelberg.de06221 396 1665

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026